---
document_datetime: 2023-09-21 18:38:37
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/coaprovel-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: coaprovel-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 3.7093756
conversion_datetime: 2025-12-30 02:01:43.114774
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

## For procedures finalised after 1 November 2004 please refer to module 8B.

- On  18  December  1998,  the  Marketing  Authorisation  Holder  (MAH)  applied  for  a  Type  I Variation  in  accordance  with  Commission  Regulation  (EC)  542/95, as  amended .  The  MAH applied for an additional alternative manufacturer for one step of the manufacturing process of the active substance. On 20 January 1999, the EMEA issued a Notification that the variation is accepted and does not require any amendment to the Community Marketing Authorisation.
- On  22  December  1998,  the  Marketing  Authorisation  Holder  (MAH)  applied  for  a  Type  I Variation  in  accordance  with  Commission  Regulation  (EC)  542/95, as  amended .  The  MAH applied for a change in the address of the Marketing Authorisation Holder (New address of the MAH: Avenue de France, 174 F-75013 Paris, France). On 20 January 1999, the EMEA issued a Notification that the variation is accepted with revisions to annexes I, IIIA and IIIB.
- On 06 January 1999, the Marketing Authorisation Holder (MAH) applied for a Type I Variation in accordance with Commission Regulation (EC) 542/95, as amended . The MAH applied for an alternative  manufacturer  of  the  active  substance.  On  05  February  1998,  the  EMEA  issued  a Notification  that  the  variation  is  accepted  and  does  not  require  any  amendment  to  the Community Marketing Authorisation.
- On  18  January  1999,  the  Marketing  Authorisation  Holder  (MAH)  applied  for  two  Type  I Variation  in  accordance  with  Commission  Regulation  (EC)  542/95, as  amended .  The  MAH applied for an increase of the size of the batch of the finished product and an introduction of a manufacturing site for all of the manufacturing process of the medicinal product. On 26 February 1999, the EMEA issued two Notifications that the variations are accepted and do not require any amendment to the Community Marketing Authorisation .
- Between 1 June and 21 December 1999, the EMEA issued Notifications for the approval of four type I variations concerning;
- -change in specification of starting material or intermediate used in the manufacture of the active substance,
- -change  in  supplier  of  an  intermediate  compound  used  in  manufacture  of  the  active substance,
- -change in the manufacture of the medicinal product,
- -minor change in manufacturing process of the active substance.

These variations did not require any amendment to the Commission Decision.

- On 3 December 1999 and 13 January 2000, the Marketing Authorisation Holder requested to introduce  changes  to  an  aspect  of  the  labelling  not  connected  to  the  Summary  of  Product Characteristics,  by  means  of  a  Notification  under  Article  10(3)  of  Directive  92/27/EEC. Following EMEA's Notification on 25 January 2000, the European Commission amended the Decision (Annex III B) on 24 March 2000.
- On 13 April 2000, the Marketing Authorisation Holder submitted a type II variation application in accordance with Article 6 of Commission Regulation (EC) No.542/95 of 10 March 1995, as amended.  The  Marketing  Authorisation  Holder  applied  for  an  update  of  the  SPC  and  PL accordingly to recently approved changes for the monotherapy product and post-marketing data. On  27  July  2000,  the  CPMP  approved  the  variation.  The  variation  required  amendments  in annex  I  and  III  B  of  the  Commission  Decision.  The  European  Commission  amended  the Decision on 16 November 2000.

1/333

<div style=\"page-break-after: always\"></div>

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                                                                                               | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Change in test procedure for starting material/intermediate used in manuf. of active substance                                                                      | I/13                 | I                        | 21.11.00                            | -                                        |
| Update of Summary of Product Characteristics and Package Leaflet                                                                                                    | II/14                | II                       | 14.12.00                            | 23.04.01                                 |
| Changes to comply with supplements to pharmacopoeias                                                                                                                | I/15                 | I                        | 20.03.01                            | -                                        |
| Change following modification(s) of the manufacturing authorisation(s)                                                                                              | I/16                 | I                        | 04.04.01                            | -                                        |
| Minor change of manufacturing process of the active substance                                                                                                       | I/17                 | I                        | 26.04.01                            | -                                        |
| Update of Summary of Product Characteristics and Package Leaflet                                                                                                    | II/18                | II                       | 20.09.01                            | 10.04.02                                 |
| Change in pack size for a medicinal product                                                                                                                         | I/19                 | I                        | 13.07.01                            | 08.10.01                                 |
| Change in pack size for a medicinal product                                                                                                                         | I/20                 | I                        | 13.07.01                            | 08.10.01                                 |
| Change in pack size for a medicinal product                                                                                                                         | I/21                 | I                        | 20.09.01                            | 19.02.02                                 |
| Change in pack size for a medicinal product                                                                                                                         | I/22                 | I                        | 20.09.01                            | 19.02.02                                 |
| Change in the name and/or address of the marketing authorisation holder                                                                                             | I/23                 | I                        | 20.09.01                            | -                                        |
| Replacement of an excipient with a comparable excipient                                                                                                             | I/24                 | I                        | 12.10.01                            | 26.02.02                                 |
| Change following modification(s) of the manufacturing authorisation(s)                                                                                              | I/25                 | I                        | 22.12.01                            | 08.03.02                                 |
| Change in test procedure for starting material/intermediate used in manuf. of active substance                                                                      | I/26                 | I                        | 10.04.02                            | 02.05.02                                 |
| Extension of shelf-life as foreseen at time of authorisation                                                                                                        | I/27                 | I                        | 20.02.02                            | 18.04.02                                 |
| Change in test procedure for starting material/intermediate used in manuf. of active substance                                                                      | I/28                 | I                        | 10.04.02                            | 20.04.02                                 |
| Minor changes in manufacture of the medicinal product                                                                                                               | I/29                 | I                        | 05.06.02                            | 18.06.02                                 |
| Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                    | N/30                 | N                        | 07.06.02                            | 28.06.02                                 |
| Extension of shelf-life or retest period of the active substance                                                                                                    | I/31                 | I                        | 21.03.03                            | 01.04.03                                 |
| Change in or addition of manufacturer(s) of active substanceMinor change of manufacturing process of the active substance                                           | I/32                 | I                        | 19.12.0223.0 4.03                   | 17.01.0329.0 4.03                        |
| Update of Summary of Product Characteristics and Package LeafletMinor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)    | NII/33               | NII                      | 17.01.0326.0 6.03                   | 07.03.0302.1 0.03                        |
| Minor change of manufacturing process of the active substanceMinor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)       | NI/34                | NI                       | 04.04.0311.0 6.03                   | 16.05.0326.0 6.03                        |
| Minor change of manufacturing process of the active substanceExtension of shelf-life or retest period of the active substance                                       | I/35                 | I                        | 12.06.0321.0 3.03                   | 01.04.0326.0 6.03                        |
| Change or addition of a new pharmaceutical formChange in or addition of manufacturer(s) of active substance                                                         | IX/36                | IX                       | 23.04.0312.1 0.03                   | 25.04.0302.0 3.04                        |
| Renewal                                                                                                                                                             | R/4137               | R                        | 25.09.03                            | 04.12.03                                 |
| Change in supplier of an intermediate compound used in manufacture of the active substance                                                                          | I/4238               | I                        | 31.10.03                            | 12.11.03                                 |
| Minor change in the manufacturing process of the active substance                                                                                                   | I/3943               | I                        | 10.11.03                            | -                                        |
| Update of Summary of Product Characteristics and Package Leaflet                                                                                                    | II/4044              | II                       | 16.09.04                            | 28.10.04                                 |
| Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. Site                                                                           | IB/415               | IB                       | 14.04.04                            | -                                        |
| Update of Summary of Product Characteristics and Package Leaflet                                                                                                    | II/426               | II                       | 03.06.04                            | 02.08.04                                 |
| Change in BR/QC testing - repl./add. of batch control/testing site and replacement/add. of manufacturing site: All other manufacturing operations ex. batch release | IB/437               | IB                       | 20.04.04                            | -                                        |
| Minor change in the manufacturing process of the active substance                                                                                                   | IB/448               | IB                       | 01.07.04                            | -                                        |
| Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                               | IA/495               | IA                       | 30.06.04                            | -                                        |
| Replacement/add. of manufacturing site: Secondary packaging site                                                                                                    | IA/5046              | IA                       | 30.06.04                            | -                                        |

2/333

<div style=\"page-break-after: always\"></div>

| and change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing   |         |    |          |    |
|---------------------------------------------------------------------------------------------|---------|----|----------|----|
| Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. Site   | IB/4751 | IB | 28.07.04 | -  |
| Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. Site   | IB/48   | IB | 29.07.04 | -  |
| Minor change in the manufacturing process of the active substance                           | IB/4953 | IB | 10.08.04 | -  |
| Change in batch size of active substance or intermediate - up to 10- fold                   | IA/4954 | IA | 17.09.04 | -  |

3/333